Atopic Dermatitis

The Pharmacy Times® Atopic Dermatitis Resource Center is a comprehensive resource for clinical news and expert insights on treatments for atopic dermatitis.

Latest News

Atopic Dermatitis, FDA Approval | Image Credit: InfiniteStudio - stock.adobe.com
FDA Approves Roflumilast for Atopic Dermatitis in Patients 6 Years and Older

July 10th 2024

Roflumilast is approved as a once daily and steroid-free cream for rapid disease clearance and significant reduction in itch and for long-term disease control.

Atopic Dermatitis, Eczema, Rash | Image Credit: InfiniteStudio - stock.adobe.com
Upadacitinib Shows Superiority to Dupilumab for Atopic Dermatitis With Dose Escalation

July 8th 2024

childhood eczema and vaping/Image Credit: © Piman Khrutmuang - stock.adobe.com
E-Cigarette Exposure May Increase Risk of Atopic Dermatitis in Children

June 18th 2024

FDA Approves Tralokinumab-ldrm Autoinjector for Adults With Atopic Dermatitis
FDA Approves Tralokinumab-ldrm Autoinjector for Adults With Atopic Dermatitis

June 13th 2024

Young girl with atopic dermatitis -- Image credit: Марина Терехова | stock.adobe.com
Pharmacists Play Crucial Role in Dupilumab Treatment for Infants, Young Children With Atopic Dermatitis

June 12th 2024

Video Interviews
Podcasts

More News